ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,112.12
-1.22%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Shield Therapeutics Plc (STX)

  7. Shield Therapeutics Plc (STX) Noticias

STX Shield Therapeutics Plc

1.55
-0.10 (-6.06%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Shield Therapeutics Plc STX London Acción Ordinaria
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.10 -6.06% 1.55 10:15:29
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.65 1.475 1.65 1.55 1.65
más cotizaciones de acciones »
Sector Industrial de la empresa
PHARMACEUTICALS & BIOTECHNOLOGY

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202413:54ALNCNewsEARNINGS AND TRADING: Software Circle & Beximco report..
30/4/202401:00UK RNSShield Therapeutics PLC Business Update for Q1 2024
16/4/202401:00UK RNSShield Therapeutics PLC Notice of Results
21/2/202406:36ALNCNewsShield Therapeutics sinks as strong performance marred by..
21/2/202401:00UK RNSShield Therapeutics PLC Unaudited Full Year Trading Update
09/1/202405:33ALNCNewsIN BRIEF: Shield Therapeutics hires former Akili leader as..
09/1/202401:00UKREGShield Therapeutics PLC Appointment of new Chief Financial..
07/12/202309:31ALNCNewsTRADING UPDATES: Comptoir opens restaurant; Intercede wins..
07/12/202301:00UKREGShield Therapeutics PLC Q3 2023 U.S. Commercial Highlights
27/11/202311:24UKREGShield Therapeutics PLC PDMR Transaction Notification
20/10/202305:45RNSNONShield Therapeutics PLC Abstract to be presented at..
12/10/202305:14ALNCNewsIN BRIEF: Shield Therapeutics Chief Financial Officer Rudolf..
12/10/202301:00UKREGShield Therapeutics PLC Chief Financial Officer Transition
03/10/202311:14ALNCNewsTRADING UPDATES: Aston Martin CEO ups stake; Alkemy's..
03/10/202309:00UKREGShield Therapeutics PLC Result of REX Retail Offer
03/10/202308:29ALNCNewsShield Therapeutics completes USD20 million SWK financing
03/10/202301:00UKREGShield Therapeutics PLC Block listing Interim Return
03/10/202301:00UKREGShield Therapeutics PLC Completion of SWK Financing
28/9/202308:54ALNCNewsUPDATE: Shield Therapeutics completes GBP5 million share..
28/9/202306:50UKREGShield Therapeutics PLC Successful completion of US$6.1m..
28/9/202305:30ALNCNewsShield Therapeutics raises funds for US sales push as loss..
28/9/202301:02UKREGShield Therapeutics PLC REX Retail Offer
28/9/202301:01UKREGShield Therapeutics PLC $20m secured debt facility &proposed..
28/9/202301:00UKREGShield Therapeutics PLC Interim results update and business..
06/9/202314:33ALNCNewsIN BRIEF: Shield Therapeutics changes reporting currency to..
06/9/202301:00UKREGShield Therapeutics PLC Notice of Results and Change in..
06/8/202311:07ALNCNewsCORRECT: Biogens, Sage Therapeutics postpartum depression..
06/8/202308:17ALNCNewsBiogens, Sage Therapeutics postpartum depression treatment..
24/7/202308:27UKREGShield Therapeutics PLC Holding(s) in Company
20/7/202305:43ALNCNewsIN BRIEF: Shield Therapeutics prescription orders up in..
20/7/202301:00UKREGShield Therapeutics PLC Business Update and U.S. Q2 2023..
28/6/202311:30UKREGShield Therapeutics PLC Results of 2023 Annual General..
16/6/202306:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
15/6/202310:35UKREGAOP Health International Management Lapse of Offer
15/6/202306:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
15/6/202301:00UKREGAOP Health International Management Acceptance Level Update
14/6/202306:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
14/6/202301:00UKREGAOP Health International Management Acceptance Level Update
13/6/202306:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
13/6/202301:00UKREGAOP Health International Management Acceptance Level Update
12/6/202306:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
12/6/202301:00UKREGAOP Health International Management Acceptance Level Update
09/6/202306:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
09/6/202301:00UKREGAOP Health International Management Acceptance Level Update
08/6/202306:31UKREGAlbemarle Life Sciences LLP Form 8.3 - Shield Therapeutics..
08/6/202306:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
08/6/202301:00UKREGAOP Health International Management Acceptance Level Update
07/6/202306:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
06/6/202306:00UKREGPeel Hunt LLP Form 8.5 (EPT/RI) - Shield Therapeutics Plc
06/6/202304:10UKREGShield Therapeutics PLC Grant of share options to the CEO

Su Consulta Reciente

LSE
STX
Shield Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados